Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
August-2017 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2017 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells

  • Authors:
    • Yoshie Yamagishi
    • Akimasa Someya
    • Kensuke Imai
    • Junji Nagao
    • Isao Nagaoka
  • View Affiliations / Copyright

    Affiliations: Department of Host Defense and Biochemical Research, Juntendo University, Graduate School of Medicine, Bunkyo‑ku, Tokyo 113‑8421, Japan, KOBAYASHI Pharmaceutical Co., Ltd., Ibaraki, Osaka 567‑0057, Japan
  • Pages: 1353-1359
    |
    Published online on: June 6, 2017
       https://doi.org/10.3892/mmr.2017.6691
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The anti-inflammatory actions of glucosamine (GlcN) on arthritic disorders involve the suppression of inflammatory mediator production from synovial cells. GlcN has also been reported to inhibit the activation of the p38 mitogen-activated protein kinase (MAPK) pathway. The present study aimed to determine the cooperative and anti‑inflammatory actions of functional food materials and evaluated the production of interleukin (IL)‑8 and phosphorylation of p38 MAPK in IL-1β-activated synovial cells, incubated with the combination of GlcN and various functional food materials containing L‑methionine (Met), undenatured type II collagen (UC‑II), chondroitin sulfate (CS), methylsulfonylmethane (MSM) and agaro-oligosaccharide (AO). The results indicated that Met, UC‑II, CS, MSM and AO slightly or moderately suppressed the IL-1β-stimulated IL‑8 production by human synovial MH7A cells. The same compounds further decreased the IL‑8 level lowered by GlcN. Similarly, they slightly suppressed the phosphorylation level of p38 MAPK and further reduced the phosphorylation level lowered by GlcN. These observations suggest a possibility that these functional food materials exert an anti‑inflammatory action (inhibition of IL‑8 production) in combination with GlcN by cooperatively suppressing the p38 MAPK signaling (phosphorylation).

Introduction

Glucosamine (GlcN), a naturally occurring amino monosaccharide, is present in the connective and cartilage tissues and contributes to maintaining their strength, flexibility and elasticity. GlcN has been widely used as a supplement for alleviating the symptoms of osteoarthritis (OA). According to previous biochemical and pharmacological findings, the administration of GlcN normalized cartilage metabolism by inhibiting degradation (1) and stimulating the synthesis of proteoglycans (2,3), and restores articular functions. GlcN has also been reported to exert an anti-inflammatory action by inhibiting the production of inflammatory mediators and inflammatory cytokines, including nitric oxide (NO), prostaglandin (PG) E2 and interleukin (IL)-8 via the suppression of the activation of the p38 mitogen activated protein kinase (MAPK) signaling pathway and nuclear factor (NF)-κB signaling (4–9).

Furthermore, other functional food materials are understood to exhibit anti-inflammatory actions. Chondroitin sulfate (CS) inhibits the activation and nuclear translocation of NF-κB in chondrocytes and synoviocytes (10). Methylsulfonylmethane (MSM) and agaro-oligosaccharide (AO) are reported to inhibit lipopolysaccharide (LPS)-induced production of NO in the RAW264.7 mouse macrophage-like cell line (11,12). In addition, AO, CS and MSM reduce the symptoms of rheumatoid arthritis models (12–14). Similarly, L-methionine (Met) reduces the symptoms of rheumatoid arthritis in model animals (15), and undenatured type II collagen (UC-II) improves the symptoms of human OA (16). Thus, these functional food materials are expected to enhance the alleviation of the symptoms of OA by combination with GlcN. However, it remains to be elucidated whether the combination of these materials with GlcN cooperatively exhibits the anti-inflammatory actions.

The present study therefore aimed to determine the cooperative and anti-inflammatory actions of functional food materials, and evaluated the production of IL-8 and phosphorylation of p38 MAPK and NF-κB in IL-1β-activated synovial cells, incubated with the combination of GlcN and various functional food materials, containing Met, UC-II, CS, MSM, AO and other substances with anti-inflammatory or anti-arthritic action (proteoglycans, hyaluronic acid, collagen peptides, olive leaf extract, red ginger extract, Boswellia serrata extract, devil's claw and curcumin).

Materials and methods

Reagents

GlcN and Met were supplied by Protein Chemical Co., Ltd. (Tokyo, Japan), UC-II by Ryusendo Co., Ltd. (Tokyo, Japan), CS by Yaegaki Bio-industry, Inc. (Himeji, Japan), MSM by CIC Frontier Co., Ltd. (Tokyo, Japan) and AO by Takara Bio Inc. (Otsu, Japan). IL-1β was purchased from Peprotech EC Ltd. (London, UK). In addition, the effects of the following substances, which are known to exhibit anti-inflammatory or anti-arthritic action (17–25), were evaluated: Proteoglycan extracted from salmon nasal cartilage (17) was supplied by Ichimaru Pharcos Co., Ltd. (Gifu, Japan), hyaluronic acid (18) by N.C. Corporation (Kagawa, Japan), collagen peptides (19,20) by Nitta Gelatin Inc. (Osaka, Japan), olive leaf extract (21) by Eisai Food & Chemical Co., Ltd. (Tokyo, Japan), red ginger extract (22) from Oryza Oil & Fat Chemical Co., Ltd. (Aichi, Japan), Boswellia serrata extract (23) from Nippon Shinyaku Co., Ltd., devil's claw extract (24) from Ask Intercity Co., Ltd. (Chiba, Japan) and curcumin (25) from Indena Japan Co., Ltd. (Tokyo, Japan).

Cell culture

MH7A human synovial cells (RCB1512) were purchased from RIKEN Cell Bank (Tsukuba, Japan) and were maintained in RPMI-1640 medium (Nacalai Tesque, Kyoto, Japan) supplemented with 10% fetal bovine serum (cat. no. 171012; Nichirei Biosciences Inc., Tokyo, Japan), penicillin and streptomycin at 37°C in 5% CO2.

Measurement of IL-8 production

MH7A cells (0.35×105 cells/well) were seeded and cultured into 24-well plates overnight. The cells were then incubated with Met (50–100 µg/ml), UC-II (50–100 µg/ml), CS (50–100 µg/ml), MSM (2,500-5,000 µg/ml), AO (50–100 µg/ml), proteoglycan (25–100 µg/ml), hyaluronic acid (250–1,000 µg/ml), collagen peptides (100–400 µg/ml), olive leaf extract (5–20 µg/ml), red ginger extract (10–40 µg/ml), devil's claw extract (25–100 µg/ml), curcumin (5–20 µg/ml) and Boswellia serrata extract (12.5 µg/ml) or GlcN (1 mM), and a combination of GlcN and other materials for 3 h at 37°C. Following this, cells were stimulated with 50 pg/ml IL-1β in a total volume of 0.5 ml RPMI-1640 medium for 24 h at 37°C (4). Subsequently, IL-8 in the culture supernatants was quantified by a sandwich enzyme-linked immunosorbent assay (ELISA) using the DuoSet ELISA Development kit (R&D Systems, Inc., Minneapolis, MN, USA). Microtiter plates (96-well half area flat bottom; Corning, Acton, MA, USA) were coated with 4 µg/ml mouse anti-human IL-8 antibody (cat. no. #890805; 180-fold dilution, 25 µl/well; R&D Systems, Inc.) diluted in phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 and 1.5 mM KH2PO4; pH7.4) overnight at 4°C. Following washing with PBS and 0.05% Tween-20, plates were blocked with PBS containing 1% bovine serum albumin (BSA) and 0.05% sodium azide for 1 h at room temperature. The plates were subsequently washed three times with PBS containing 0.05% Tween-20, 25 µl/well culture supernatants or standards (15–2,000 pg/ml) were added, and plates were incubated for 2 h at room temperature. Following washing three times with PBS containing 0.05% Tween-20, the plates were incubated with 3.6 µg/ml of biotinylated goat anti-human IL-8 antibody (180-fold dilution; cat. no. #890805, R&D Systems, Inc.) for 2 h at room temperature, then washed and incubated with streptavidin-horseradish peroxidase (cat. no. #890803; 200-fold dilution, 25 µl/well; R&D Systems, Inc.) at room temperature for 10 min. The plates were washed again and incubated with 25 µl tetramethyl benzidine liquid substrate. The reaction was terminated with 1 M H2SO4, and the plates were read immediately at a wavelength of 450 nm with a microplate reader (Model 680; Bio-Rad, Hercules, CA, USA). The detection limit was <15 pg/ml.

Phosphorylation of p38MAPK and NF-κB

MH7A cells (9×105/well) were seeded and cultured in 35 mm tissue culture dishes overnight. Thereafter, the cells were incubated with 1 mM GlcN, 100 µg/ml Met, 50 µg/ml UC-II, 50 µg/ml CS or 2,500 µg/ml MSM, 100 µg/ml AO and a combination of GlcN and other materials for 3 h, and stimulated with 200 pg/ml IL-1β for 10 min at 37°C (8,9). Following washing with ice-cold PBS containing 100 mM Na3VO4, the cells were harvested in 1.2 ml lysis buffer (1% Triton X-100, 0.5% Nonidet P-40, 10 mM Tris-HCl and 150 mM NaCl; pH 7.4) containing 1/25 v/v Complete™ (Roche Diagnostics GmbH, Mannheim, Germany) and 1/100 v/v Phosphatase Inhibitor Cocktail™ (Nacalai Tesque, Kyoto, Japan). Following sonication, the lysates were centrifuged at 4°C at 12,000 × g for 10 min and the supernatants were recovered. The protein concentrations of the supernatants were determined with a Bicinchoninic Acid protein assay kit (Pierce; Thermo Fisher Scientific, Inc., Waltham, MA, USA) using BSA as a standard. The supernatants were mixed with 6X SDS-PAGE sample buffer and boiled for 3 min. Samples (10 µg protein/lane) were separated by 12% SDS-PAGE and electrophoretically transferred onto an Immobilon-P polyvinylidene difluoride membrane (EMD Millipore, Billerica, MA, USA). To detect phosphorylated p38 MAPK and NF-κB levels, the membranes were blocked in Blocking One solution (Nacalai Tesque, Inc., Kyoto, Japan), and probed with a mouse anti-phosphorylated (p)-p38 MAPK monoclonal antibody (pT180/pY182; 1,000-fold dilution; cat. no. #612168; BD Bioscience Pharmingen, San Diego, CA, USA) or a rabbit anti-phosphorylated NF-κB p65 monoclonal antibody (Ser 536; 250-fold dilution; cat. no. #3033; Cell Signaling Technology, Inc., Danvers, MA, USA). Horseradish peroxidase (HRP)-conjugated goat anti-mouse immunoglobulin (Ig)G/IgM (5,000-fold dilution; cat. no. #115-035-044; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) or HRP-conjugated goat anti-rabbit IgG (5,000-fold dilution; cat. no. #115-035-144; Jackson ImmunoResearch Laboratories, Inc.) served as secondary antibodies.

The membranes were stripped by incubating in Restore Western Stripping Buffer (Pierce; Thermo Fisher Scientific, Inc.) at 37°C for 15 min. The p38 MAPK and NF-κB proteins contained in each sample were detected by reprobing with mouse anti-p38MAPK (2,000-fold dilution; SAPK2a; cat. no. #612168; BD Bioscience Pharmingen) or rabbit anti-NF-κB (2,000-fold dilution; D14E12; cat. no. #8242; Cell Signaling Technology, Inc.) primary antibodies followed by the HRP-conjugated goat anti-mouse (5,000-fold dilution) or anti-rabbit (5,000-fold dilution) IgG secondary antibodies. Signals were detected with SuperSignal West Pico Chemiluminescent Substrate (Pierce; Thermo Fisher Scientific, Inc.), and quantified using a LAS-3000 luminescent image analyzer and Multi Gauge version 3.0 (both from Fujifilm Corporation, Tokyo).

Statistical analysis

Data are expressed as the mean ± standard deviation, and were analyzed using one-way analysis of variance followed by a post hoc Bonferroni test for multiple comparisons. Statistical analysis was performed using GraphPad Prism software version 5 (GraphPad Software, Inc., La Jolla, CA, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

Effects of Met, UC-II, CS, MSM, AO and GlcN on IL-1β-stimulated IL-8 production by MH7A cells

To evaluate the effects of functional food materials and GlcN on IL-8 production, MH7A was stimulated with IL-1β in the presence of Met, UC-II, CS, MSM, AO or GlcN, and the combination of GlcN and other materials. Met (50 and 100 µg/ml), UC-II (50 and 100 µg/ml), CS (50 and 100 µg/ml), MSM (2,500 and 5,000 µg/ml) and AO (50 and 100 µg/ml) slightly or moderately suppressed the IL-1β-stimulated IL-8 production by MH7A cells (Fig. 1A-E, respectively), although GlcN (1 mM) suppressed IL-8 production more potently compared with other materials (Fig. 1). The combination of GlcN and these functional food materials on IL-8 production was evaluated. Met (100 µg/ml), UC-II (50 µg/ml), CS (50 µg/ml), MSM (2,500 and 5,000 µg/ml, P<0.05) and AO (100 µg/ml, P<0.01) further decreased the IL-8 level lowered by GlcN (Fig. 1A-E, respectively). In contrast, proteoglycan (25–100 µg/ml), hyaluronic acid (250–1,000 µg/ml), collagen peptides (100–400 µg/ml), olive leaf extract (5–20 µg/ml), red ginger extract (10–40 µg/ml), devil's claw extract (25–100 µg/ml), curcumin (5–20 µg/ml) and Boswellia serrata extract (12.5 µg/ml) neither suppressed the IL-1β-stimulated IL-8 production by MH7A cells nor affected the GlcN-induced suppression of IL-8 production (data not shown).

Figure 1.

Effect of functional food materials and glucosamine (GlcN) on IL-1β-stimulated IL-8 production by MH7A cells. MH7A cells were incubated in the absence (−) or presence (+) of (A) Met (B) UC-II, (C) CS, (D) MSM and (E) AO, in with or without or GlcN and IL-1β. Data are presented as the mean ± standard deviation of three separate experiments. The level of IL-1β-stimulated IL-8 production was compared between cells with and without functional food materials or glucosamine, and between cells treated with glucosamine alone and those treated with a combination of functional food materials and glucosamine. *P<0.05, **P<0.01 and ***P<0.001. IL, interleukin. Met, methionine; UC-II, undenatured type II collagen; CS, chondroitin sulfate; MSM, methysulfonylmethane; AO, agaro-oligosaccharide; GlcN, glucosamine; IL-1β, interleukin-1β.

Effects of Met, UC-II, CS, MSM, AO and GlcN on phosphorylation of p38 MAPK and NF-κB

To determine whether the suppressive action of Met, UC-II, CS, MSM, AO or GlcN, and the combination of GlcN and other materials on the synovial cell activation is mediated by the actions of p38 MAPK and NF-κB signaling, the effects of these substances on the phosphorylation of p38 MAPK and NF-κB p65 was investigated. Met (100 µg/ml), UC-II (50 µg/ml), CS (50 µg/ml), MSM (2,500 µg/ml) and AO (100 µg/ml) slightly or moderately suppressed the IL-1β-stimulated phosphorylation of p38 MAPK (Fig. 2A-E, respectively), although GlcN (1 mM) substantially suppressed the IL-1β-induced phosphorylation of p38 MAPK (Fig. 2). Notably, Met, UC-II, CS, MSM and AO slightly or moderately decreased the phosphorylation level of p38 MAPK lowered by GlcN. In addition, Met further reduced the phosphorylation level of NF-κB p65 lowered by GlcN (Fig. 3), although the suppressive effects of UC-II, CS, MSM and AO on the phosphorylation of NF-κB p65 were not clearly observed (data not shown). However, the suppressive effects of Met, UC-II, CS, MSM, AO and GlcN on the phosphorylation levels of p38 MAPK and NF-κB p65 were not statistically significant (data not shown).

Figure 2.

Effect of functional food materials and glucosamine on the phosphorylation of p38 MAPK. Representative western blot images of MH7A cells incubated in the absence (−) or presence (+) of (A) Met, (B) UC-II, (C) CS, (D) MSM, (E) AO, with or without or GlcN and IL-1β. Images and quantified data are representative of three separate experiments. MAPK, mitogen-activated protein kinase; Met, methionine; UC-II, undenatured type II collagen; CS, chondroitin sulfate; MSM, methysulfonylmethane; AO, agaro-oligosaccharide; GlcN, glucosamine; IL-1β, interleukin-1β; pp38, phosphorylated p38.

Figure 3.

Effect of Met and GlcN on phosphorylation of NF-κB p65. Representative western blot images of MH7A cells incubated in the absence (−) or presence (+) of Met, with or without GlcN and IL-1β. Images and quantified data are the representative of three separate experiments. NF-κB, nuclear factor-κB; Met, methionine; GlcN, glucosamine; IL-1β, interleukin-1β; p, phosphorylated.

Discussion

The anti-inflammatory actions of GlcN in arthritic disorders involve the suppression of inflammatory mediator production from synovial cells and chondrocytes (4–6). In addition, GlcN has been reported to inhibit activation of the p38 MAPK NF-κB signaling pathways (4,6–9). The present study examined the anti-inflammatory actions of other functional food materials; the effects of Met, UC-II, CS, MSM and AO were evaluated using the MH7A human synovial cell line, and IL-8 as an inflammatory cytokine/chemokine. The results indicated that Met, UC-II, CS, MSM and AO slightly or moderately suppressed IL-1β-stimulated IL-8 production by MH7A cells. Notably, Met, UC-II, CS, MSM and AO further decreased the IL-8 levels lowered by GlcN. Similarly, Met, UC-II, CS, MSM and AO slightly or moderately suppressed the phosphorylation levels of p38 MAPK and further reduced the phosphorylation level lowered by GlcN (statistical data not shown). These observations suggested a possibility that these functional food materials exerted an anti-inflammatory action (inhibition of IL-8 production) in combination with GlcN by cooperatively suppressing p38 MAPK signaling (phosphorylation).

The functional food materials evaluated in the present study are included in various foods (http://www.naturaldatabase.com/): GlcN is contained in the shells of crustaceans, including shrimps and crabs; Met is contained mainly in meat, vegetables and nuts; UC-II and CS are contained in cartilage; MSM is present in milk, tea and vegetables; and, AO is contained in agar. GlcN has been reported to suppress the progression of adjuvant arthritis by inhibiting synovial hyperplasia, cartilage destruction, inflammatory cell infiltration and the production of inflammatory mediators (NO and PGE2) (26). Furthermore, GlcN suppressed the progression of an experimental OA model by inhibiting type II collagen degradation and enhancing type II collagen synthesis (27). Among the functional food materials, Met is reported to suppress the progression of adjuvant arthritis by inhibiting the synovial hyperplasia and production of inflammatory mediators (NO and PGE2) (15). CS exerts an anti-inflammatory action by reducing NF-κB nuclear translocation in synoviocytes and chondrocytes (10). AO suppresses the elevated levels of NO, PGE2, and pro-inflammatory cytokines including tumor necrosis factor (TNF)-α, IL-1β and IL-6 by inducing heme oxygenase-1 in LPS-stimulated monocytes and macrophages (28). MSM inhibits the LPS-induced release of inflammatory mediators (NO, PGE2, IL-6 and TNF-α) in murine macrophages through the downregulation of NF-κB signaling (11). UC-II suppresses collagen-induced arthritis by inducing CD4+CD25+ regulatory T cells (29). Met reduces the symptoms of rheumatoid arthritis in model animals (15). AO, CS and MSM reduce the symptoms of rheumatoid arthritis models (12–14). UC-II improves the symptoms of human OA (16). The present study revealed that these functional food materials slightly inhibit the activation of synovial cells by suppressing IL-8 production and p38 MAPK signaling by themselves. Furthermore, the combinations of these functional food materials and GlcN cooperatively inhibit the synovial cell activation (IL-8 production) and p38 MAPK signaling. Therefore, the combinations of these materials and GlcN are expected to exhibit the chondroprotective action on cartilage-degenerative diseases including OA and rheumatoid arthritis by suppressing p38 MAPK signaling.

IL-1β activates a variety of signaling cascades (including p38MAPK and NF-κB pathways), which lead to the induction of inflammatory response (i.e., the production of inflammatory cytokines and mediators) (30,31). The present study demonstrated that GlcN and other functional food materials (mentioned above) cooperatively suppress the IL-1β-induced IL-8 production and the phosphorylation of p38MAPK (Figs. 2 and 3) (data not shown). These observations suggest that GlcN and other functional food materials inhibit the IL-1β-induced synovial cell activation (i.e., IL-8 production) possibly via the suppression of intracellular signaling including p38MAPK.

It is now recognized that the addition of O-linked N-acetylGlcN (O-GlcNAc) to target proteins may modulate cellular functions, including nuclear transport, transcription, translation, cell signaling, apoptosis and cell shape (32,33). We previously suggested (8) that GlcN suppressed the TNF-α-induced intercellular adhesion molecule (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) expression in endothelial cells, possibly by downregulating the phosphorylation of p38 MAPK and NF-κB via O-GlcNAc modification, using an O-GlcNAc transferase (OGT) inhibitor, alloxan. Thus, it is reasonable to hypothesize that GlcN inhibits the IL-1β-induced synovial cell activation (i.e., IL-8 production), possibly by downregulating the phosphorylation of p38 MAPK and NF-κB via O-GlcNAc modification. However, it remains unclear whether O-GlcNAc modification is involved in the suppression of p38 MAPK and NF-κB phosphorylation by other functional food materials evaluated in this study.

By contrast, proteoglycan, hyaluronic acid, collagen peptides, olive leaf extract, red ginger extract, Boswellia serrata extract, devil's claw extract and curcumin did not suppress the IL-1β-stimulated IL-8 production by MH7A cells under the experimental conditions of the present study (data not shown). Proteoglycan is reported to attenuate the progression of collagen-induced arthritis by modulating immune response of splenocytes to collagen stimulation (17). Hyaluronic acid exerts the anti-inflammatory action by inhibiting bradykinin-induced arachidonic acid release from synovial fibroblasts in osteoarthritic inflamed joints (18). Collagen peptides exert a chondroprotective action on OA by inhibiting matrix metalloproteinase-13 expression and type II collagen degeneration (19). Olive leaf extract exhibits the anti-arthritis effect by preventing the destruction of cartilage and limiting peri-articular soft tissue inflammation in kaolin- and carrageenan-induced arthritis (21). An active substance of red ginger extract, 6-Gingerol, exerts its anti-inflammatory action by reducing the inducible nitric oxide synthase and TNF-α expression through the blocking of NF-κB and protein kinase c signaling in LPS-stimulated macrophages (22). Boswellia serrata exhibits an anti-inflammatory action on colonic epithelial cells by suppressing cytokine- and hydrogen peroxide-induced activation of NF-κB (23). Harpagophytum procumbens (devil's claw) suppresses the inflammatory reaction of LPS-stimulated human monocytes by inhibiting the release of cytokines and PGE2, and the expression of COX-2, IL-6 and TNF-α mRNA, without affecting the NF-κB and MAPK signaling pathways (24). Curcumin reduces LPS-stimulated inflammatory responses (NO, PGE2 and cytokine production) in the lungs of diabetic rats by suppressing NF-κB activation (25). Thus, all the functional food materials described above are unlikely to exhibit anti-inflammatory actions on IL-1β-induced production of IL-8 by synovial cells evaluated in the present study, although they suppress the inflammatory reactions assessed under other experimental conditions.

In conclusion, the present study demonstrated that a combination of functional food materials (Met, UC-II, CS, MSM and AO) and GlcN resulted in a chondroprotective action on cartilage-degenerative diseases. However, it is for future studies to elucidate whether the combinations of these functional food materials and GlcN exerts a therapeutic action in vivo, using animal models of OA and rheumatoid arthritis.

Acknowledgements

The present study was supported in part by a grant from the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science and Technology (Tokyo, Japan; 2014 to 2018; grant no. S1411007). The authors would like to thank Dr. K Miyazawa (Kissei Pharmaceutical Co., Ltd., Nagano, Japan) for the establishment of MH7A cells, and the researchers of Department of Host Defense and Biochemical Research, Juntendo University, Graduate School of Medicine, for technical assistance and helpful discussions.

References

1 

Fenton JI, Chlebec-Brown KA, Peters TL, Caron JP and Orth MW: Glucosamine HCl reduces equine articular cartilage degradation in explants culture. Osteoarthritis Cartilage. 8:258–265. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Oegema TR Jr, Deloria LB, Sandy JD and Hart DA: Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits. Arthritis Rheum. 46:2495–2503. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Gouze JN, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J, Fournel-Giqleux S and Ouzzine M: Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: Influence of glucosamine on Interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum. 44:351–360. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Hua J, Sakamoto K, Kikukawa T, Abe C, Kurosawa H and Nagaoka I: Evaluation of the suppressive actions of glucosamine on the interleukin-1beta-mediated activation of synoviocytes. Inflamm Res. 56:432–438. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Nagaoka I: Recent aspects of the chondroprotective and anti-inflammatory actions of glucosamine, a functional food. Juntendo Medical J. 60:580–587. 2014. View Article : Google Scholar

6 

Largo R, Alvarez-Soria MA, Díez-Ortego I, Sánchez-Pernatute O, Eqido J and Herrero-Beaumont G: Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocyte. Osteoarthritis Cartilage. 11:290–298. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Rafi MM, Yadav PN and Rossi AO: Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB. Mol Nutr Food Res. 51:587–593. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Ju Y, Hua J, Sakamoto K, Ogawa H and Nagaoka I: Modulaion of TNF-α-induced endothelial cell activation by glucosamine, a naturally occurring amino monosaccharide. Int J Mol Med. 22:809–815. 2008.PubMed/NCBI

9 

Yomogida S, Hua J, Sakamoto K and Nagaoka I: Glucosamine suppresses interleukin-8 production and ICAM-1expression by TNF-α-stimulated human colonic epithelial HT-29 cells. Int J Mol Med. 22:205–211. 2008.PubMed/NCBI

10 

Iouv M, Dumais G and du Souich P: Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 16 Suppl 3:S14–S18. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Kim YH, Kim DH, Lim H, Baek DY, Shin HK and Kim JK: The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biol Pharm Bull. 32:651–656. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Ohnogi H, Kudo Y, Hayami S, Mizutani S and Enoki T: Synergistic anti-inflammatory effects of agaro-oligosaccharides and glucosamine in vivo and in vitro. Glucosamine Res. 8:51–56. 2012.(In Japanese).

13 

Volpi N: Anti-inflammatory activity of chondroitin sulphate: New functions from an old natural macromolecule. Inflammopharmacology. 19:299–306. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Hasegawa T, Ueno S and Kumamoto S: Suppressive effect of methylsulphonylmethane (MSM) on type II collagen-induced arthritis in DBA/1J mice. Jpn Pharmacol Ther. 32:421–427. 2004.

15 

Yamagishi Y, Igarashi M, Suzuki A, Suguro S, Hirano SI and Nagaoka I: Evaluation of the effect of methionine and glucosamine on adjuvant arthritis in rats. Exp Ther Med. 4:640–644. 2012.PubMed/NCBI

16 

Lugo JP, Saiyed ZM and Lane NE: Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: A multicenter randomized, double-blind, placebo-controlled study. Nutr J. 15:142016. View Article : Google Scholar : PubMed/NCBI

17 

Yoshimura S, Asano K and Nakane A: Attenuation of collagen-induced arthritis in mice by salmon proteoglycan. Biomed Res Int. 2014:4064532014. View Article : Google Scholar : PubMed/NCBI

18 

Tobetto K, Yasui T, Ando T, Hayashi M, Motohashi N, Shinogi M and Mori I: Inhibitort effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblast. Jap J Pharmacol. 60:79–84. 1992. View Article : Google Scholar : PubMed/NCBI

19 

Isaka S, Someya A, Nakamura S, Naito K, Nozawa M, Inoue N, Sugihara F, Nagaoka I and Kaneko K: Evaluation of the effect of oral administration of collagen peptides on an experimental rat osteoarthritis model. Exp Ther Med. (In press). PubMed/NCBI

20 

Ohara H, Matsumoto H, Ito K, Iwai K and Sato K: Comparison of quantity and structures of Hydroxyproline-containing peptides in human blood after oral ingestion of gelatin hydrolysates from different sources. J Agric Food Chem. 55:1532–1535. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Gong D, Geng C, Jiang L, Wang L, Yoshimura H and Zhong L: Mechanisms of olive leaf extract-ameliorated rat arthritis caused by kaolin and carrageenan. Phytother Res. 26:397–402. 2012.PubMed/NCBI

22 

Lee TY, Lee KC, Chen SY and Chang HH: 6-Gingerol inhibits ROS and iNOS through the suppression of PKC-alpha and NF-kappaB pathways in lipopolysaccharide-stimulated mouse macrophages. Biochem Biophys Res Commun. 382:134–139. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Catanzaro D, Rancan S, Orso G, Dall'Acqua S, Brun P, Giron MC, Carrara M, Castagliuolo I, Ragazzi E, Caparrotta L and Montopoli M: Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage. PLoS One. 10:e01253752015. View Article : Google Scholar : PubMed/NCBI

24 

Fiebich BL, Muñoz E, Rose T, Weiss G and McGregor GP: Molecular targets of the antiinflammatory Harpagophytum procumbens (devil's claw): Inhibition of TNFα and COX-2 gene expression by preventing activation of AP-1. Phytother Res. 26:806–811. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Zhang F, Yang F, Zhao H and An Y: Curcumin alleviates lung injury in diabetic rats by inhibiting NF-κB pathway. Clin Exp Pharmacol Physiol. 2015.(Epub ahead of print). View Article : Google Scholar

26 

Hua J, Suguro S, Sakamoto K and Nagaoka I: Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res. 54:127–132. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Naito K, Watari T, Furuhata A, Yomogida S, Sakamoto K, Kurosawa H, Kaneko K and Nagaoka I: Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. Life Sci. 86:538–543. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Enoki T, Okuda S, Kudo Y, Takshima F, Sagawa H and Kato I: Oligosaccharides from agar inhibit pro-inflammatory mediator release by inducing heme oxygenase 1. Biosci Biotechnol Biochem. 74:766–770. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Yoshinari O, Shiojima Y, Moriyama H, Shinozaki J, Nakane T, Masuda K and Bagchi M: Water-soluble undenaturated type II collagen ameliorates collagen-induced arthritis in mice. J Med Food. 16:1039–1045. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Parhar K, Ray A, Steinbrecher U, Nelson C and Salh B: The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. Immunology. 108:502–512. 2003. View Article : Google Scholar : PubMed/NCBI

31 

Hu DN, Chen M, Zhang DY, Ye F, McCormick SA and Chan CC: Interleukin-1beta increases baseline expression and secretion of interleukin-6 by human uveal melanocytes in vitro via the p38 MAPK/NF-kappaB pathway. Invest Ophthalmol Vis Sci. 52:3767–3774. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Wells L, Vosseller K and Hart GW: Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc. Science. 291:2376–2378. 2001. View Article : Google Scholar : PubMed/NCBI

33 

Hanover JA: Glycan-dependent signaling: O-linled N-acetylglucosamine. FASEB J. 15:1865–1876. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yamagishi Y, Someya A, Imai K, Nagao J and Nagaoka I: Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells. Mol Med Rep 16: 1353-1359, 2017.
APA
Yamagishi, Y., Someya, A., Imai, K., Nagao, J., & Nagaoka, I. (2017). Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells. Molecular Medicine Reports, 16, 1353-1359. https://doi.org/10.3892/mmr.2017.6691
MLA
Yamagishi, Y., Someya, A., Imai, K., Nagao, J., Nagaoka, I."Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells". Molecular Medicine Reports 16.2 (2017): 1353-1359.
Chicago
Yamagishi, Y., Someya, A., Imai, K., Nagao, J., Nagaoka, I."Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells". Molecular Medicine Reports 16, no. 2 (2017): 1353-1359. https://doi.org/10.3892/mmr.2017.6691
Copy and paste a formatted citation
x
Spandidos Publications style
Yamagishi Y, Someya A, Imai K, Nagao J and Nagaoka I: Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells. Mol Med Rep 16: 1353-1359, 2017.
APA
Yamagishi, Y., Someya, A., Imai, K., Nagao, J., & Nagaoka, I. (2017). Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells. Molecular Medicine Reports, 16, 1353-1359. https://doi.org/10.3892/mmr.2017.6691
MLA
Yamagishi, Y., Someya, A., Imai, K., Nagao, J., Nagaoka, I."Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells". Molecular Medicine Reports 16.2 (2017): 1353-1359.
Chicago
Yamagishi, Y., Someya, A., Imai, K., Nagao, J., Nagaoka, I."Evaluation of the anti-inflammatory actions of various functional food materials including glucosamine on synovial cells". Molecular Medicine Reports 16, no. 2 (2017): 1353-1359. https://doi.org/10.3892/mmr.2017.6691
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team